Navigation Links
MDC researchers develop new tool to investigate ion channels
Date:2/10/2010

Neurotoxins from cone snails and spiders help neurobiologists Sebastian Auer, Annika S. Strzebecher and Dr. Ines Ibaez-Tallon of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, to investigate the function of ion channels in neurons. Ion channels in the cell membrane enable cells to communicate with their environment and are therefore of vital importance. The MDC researchers have developed a system which for the first time allows the targeted, long-lasting investigation of ion channel function in mammals and also the blockade of the ion channels with neurotoxins. In transgenic mice they succeeded in blocking chronic pain by introducing a toxin gene into the organism (Nature Method, doi:10.1038/NMETH.1425)*.

There are approximately 500 species of cone snails, each producing 50 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.

Scientists estimate that more than 100,000 neurotoxins exist. They have become a topic of enormous research interest: Using neurotoxins researchers can target different ion channels, receptors and other signaling molecules and characterize their physiological function.

This kind of research can also give them insight into disease processes and eventually help them to find new therapies to eventually block hyperactive ion channels. For instance, a compound (Ziconotide) based on the toxin of a cone snail is already used to treat severe chronic pain in patients.

Dr. Ibaez-Tallon's research group is concentrating on two ion channels in the membrane of neurons which are activated by electric stimulation (action potential). Once activated, they allow the influx of calcium ions into the neuron, and the cell then releases chemicals (neurotransmitters), which send the signal to the next neuron.

During the last decades soluble neurotoxins have greatly helped in the characterization of ion channels and receptors because of their ability to specifically bind and inhibit these channels. However, soluble neurotoxins can only be applied for limited time, and their activity cannot be directed to specific cells.

Sebastian Auer, Annika S. Strzebecher and Dr. Ibaez-Tallon managed to circumvent this problem with genetic engineering. Using lentiviruses they developed a shuttle to deliver the genes of cone snail and spider toxins into the neurons. The result: The neurons now long-lastingly produce toxins which directly bind to the calcium ion channels the researchers want to investigate. This was the first step the targeted and long-lasting binding of the toxins to a specific ion channel in the cell culture.

Secondly, the researchers were able to demonstrate that with their tool they can also express toxin genes in animals in a targeted way and also lastingly characterize ion channels. In transgenic mice they were able to block certain calcium ion channels with their toxins and thus block chronic pain.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert  

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MDC researchers develop new tool to investigate ion channels
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
(Date:1/7/2016)... -- A United States District Court in Illinois ... to interpret a biometric privacy statute in a decision ... photo website Shutterfly brought by the law firm Carey Rodriguez ... SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. Ill ., ... Illinois Biometric Privacy Act by collecting and scanning face ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... talent development and compliance training, today announced an interactive FDA compliance training ... The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today provided an ... in the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings ... Office.  The IPR was initiated on only certain claims ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, Inc ... the first pluripotent stem cell-derived islet replacement therapy ... clinical-stage development, today announced that ViaCyte and Janssen ... of Johnson & Johnson, have agreed to consolidate ... ViaCyte.  The agreement provides ViaCyte with an exclusive ...
Breaking Biology Technology: